The molecular basis of reactive amyloidosis.
Reactive amyloidosis is a disease occurring in patients suffering from chronic infections, inflammation, and certain malignant conditions that are characterized by a considerable elevation of the acute phase reactant serum amyloid A (SAA). It is defined by the presence of extracellular deposits of fibrillar material containing amyloid A (AA) as its main component. AA is an 8.5-kd protein structurally identical to the NH2-terminal of the acute phase reactant SAA. SAA consists of a group of evolutionally conserved amphipathic proteins, encoded by a large number of genes and produced abundantly during inflammation, all suggesting an important role, probably of a neutralizing (anti-inflammatory) nature. An analysis of various aspects of SAA provides no clues to the mechanism of amyloid production, its occurrence in only selected individuals, and its preferential relationship to one isotype of SAA. Until more data is available, the present view on AA amyloidogenesis remains hypothetical.
Yakar
S
S
Sackler Medical School, Tel-Aviv University, Israel.
Livneh
A
A
Kaplan
B
B
Pras
M
M
D000595:Amino Acid Sequence; D000686:Amyloidosis / Q000209:etiology* / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000150:complications*; D008969:Molecular Sequence Data; D000685:Serum Amyloid A Protein / Q000032:analysis*
D000685:Serum Amyloid A Protein